about
Identification of druggable cancer driver genes amplified across TCGA datasetsCell-free nucleic acids as noninvasive biomarkers for colorectal cancer detectionK-ras/PI3K-Akt signaling is essential for zebrafish hematopoiesis and angiogenesisEffect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeLung epithelial branching program antagonizes alveolar differentiationThe STK33-linked SNP rs4929949 is associated with obesity and BMI in two independent cohorts of Swedish and Greek childrenA graph theoretic approach to utilizing protein structure to identify non-random somatic mutations.Utilizing protein structure to identify non-random somatic mutations.Molecular markers of paragangliomas/pheochromocytomasMicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway.Clinical relevance of KRAS in human cancers.Integrating multi-omics for uncovering the architecture of cross-talking pathways in breast cancer.Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer.The involvement of Kras gene 3'-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis.Current concepts on the molecular pathology of non-small cell lung carcinoma.Retrospective analysis of KRAS status in metastatic colorectal cancer patients: a single-center feasibility studyAssociation between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors.DNA damage activates a complex transcriptional response in murine lymphocytes that includes both physiological and cancer-predisposition programs.Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells.Activation of KRAS promotes the mesenchymal features of basal-type breast cancer.Molecularly targeted therapies in non-small-cell lung cancer annual update 2014CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathwayCellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrixBioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis.A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPDOncogenic KRAS regulates BMP4 expression in colon cancer cell lines.The role of molecular pathology in non-small-cell lung carcinoma-now and in the future.Network analysis of microRNAs and genes in human osteosarcoma.An Encapsulation of Gene Signatures for Hepatocellular Carcinoma, MicroRNA-132 Predicted Target Genes and the Corresponding OverlapsChanges in gene-expression profiles of colon carcinoma cells induced by wild type K-ras2.rs712 polymorphism within let-7 microRNA-binding site might be involved in the initiation and progression of colorectal cancer in Chinese populationAssociation between the KRAS Gene Polymorphisms and Papillary Thyroid Carcinoma in a Chinese Han Population.Efficient Generation of Mice with Consistent Transgene Expression by FEEST.Prognostic and predictive roles of KRAS mutation in colorectal cancer.Roles of palmitoylation and the KIKK membrane-targeting motif in leukemogenesis by oncogenic KRAS4AA developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas.Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene MutationsGenetics of Bladder Malignant Tumors in ChildhoodContextualizing the Genes Altered in Bladder Neoplasms in Pediatric andTeen Patients Allows Identifying Two Main Classes of Biological ProcessesInvolved and New Potential Therapeutic TargetsIntrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY phosphorylation
P2860
Q21090621-14D72930-BE9A-4148-9FB0-37E69534E760Q26991998-427D512E-8A6A-4BF4-9A8E-43134333DB01Q27300812-96FFA5D9-46C5-4E30-B3DE-33102FB40312Q27851703-3383EB54-F196-4AB0-AC10-B8DEA70FB111Q28504589-29293597-0EED-4D92-A026-52E72D89734AQ28535388-83177239-D31D-4CD6-A43E-2DDA095DEF83Q30360645-AA2A8785-3EA3-4490-94FA-FC3FF40E9812Q30431811-CD6DA2D3-7481-4B5D-902C-7189FA12C6D2Q33649025-AAB233EC-2C87-40A0-8351-0B1D9A33DB93Q33859390-4BCBD9D7-72FF-4091-9E1D-F491BF5D66C7Q33959887-AC34E427-6F10-4B39-95A4-BE2847C4C1D4Q34066320-222A3D4F-13EA-47B2-87A6-25E94DCF0411Q34101115-3CC99B54-2600-452E-BE94-320DB9A0EF2EQ34134870-7B6088AC-7B86-42A9-813F-24BDC12478B3Q34310062-4F606688-131F-44B3-ABAF-1027AED65BE8Q34426265-BAC82CE2-603F-46A6-889E-B945107ECE0FQ34607305-8EE86A2D-45DC-4BB0-B89C-D9979FD0D305Q34621580-B27ABDB2-7A1E-4AAF-A8DF-EAAF8999FABAQ34992198-E9B56950-F4FD-45BD-B8AB-77C857B9E16AQ35040663-9CF0C314-6021-4058-9A48-0A309CD4793EQ35136424-E94BE627-A64B-4256-ABC3-1A520E6C19F8Q35803419-376EA87C-FE4D-4C9C-AF45-452C08C10567Q35832096-076289E1-D217-4AB3-8AEF-AFC42AE8EAF5Q35865494-D614F949-4587-42B6-B5CF-B5CF3D042C4FQ35981873-807EF177-F8AC-45FC-A9D2-EA425092E539Q35994053-4E4767A8-577A-4B70-99ED-F0F072561DECQ36040599-95E2A84F-AE0E-47BD-BA37-1A22F9215F18Q36081276-4FEB0F13-4ACE-48B1-8335-3A6A74B8F172Q36088484-555DB1D8-97D4-4B2E-B901-9086E385EEDFQ36179958-242313AE-435F-4DA5-AD5E-2434A07ADD3DQ36212703-76577FFB-B346-4BB6-B930-057D1B14998FQ36229033-A2D2DBB2-A711-47E5-BB00-CE0FC54B901EQ36287660-25B81A33-C638-4BFA-9F17-954D56554D55Q36396396-4AC267A3-E566-489B-853E-C0D46A3F1B51Q36416861-B16B43D1-B247-4768-ABAE-FE86A2C9BB41Q36512275-4464A8AE-C693-40FC-8804-C479D4CBF556Q36535735-3B37E14A-6678-4457-9FE4-2800DCD3011BQ36658484-F94C3D20-69F4-4821-A973-75C10C2ACDF4Q36658489-6EB31661-7B48-4812-ACD6-21BCEB99003DQ36685109-36BCC683-EC4E-4927-9DFD-866010873F67
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The KRAS oncogene: past, present, and future
@ast
The KRAS oncogene: past, present, and future
@en
The KRAS oncogene: past, present, and future
@nl
type
label
The KRAS oncogene: past, present, and future
@ast
The KRAS oncogene: past, present, and future
@en
The KRAS oncogene: past, present, and future
@nl
prefLabel
The KRAS oncogene: past, present, and future
@ast
The KRAS oncogene: past, present, and future
@en
The KRAS oncogene: past, present, and future
@nl
P3181
P1476
The KRAS oncogene: past, present, and future
@en
P2093
Onno Kranenburg
P3181
P356
10.1016/J.BBCAN.2005.10.001
P407
P577
2005-11-25T00:00:00Z